Display options
Cite
Winkel E, Costanzo MR, Parrillo J. Myocarditis. Curr Treat Options Cardiovasc Med. 2000;2(5):407-420doi: 10.1007/s11936-000-0036-8.
Winkel, E., Costanzo, M. R., & Parrillo, J. (2000). Myocarditis. Current treatment options in cardiovascular medicine, 2(5), 407-420. https://doi.org/10.1007/s11936-000-0036-8
Winkel, et al. "Myocarditis." Current treatment options in cardiovascular medicine vol. 2,5 (2000): 407-420. doi: https://doi.org/10.1007/s11936-000-0036-8
Winkel E, Costanzo MR, Parrillo J. Myocarditis. Curr Treat Options Cardiovasc Med. 2000 Oct;2(5):407-420. doi: 10.1007/s11936-000-0036-8. PMID: 11096545.
Copy Download .nbib Format: NLM
Share it on

Curr Treat Options Cardiovasc Med. 2000 Oct;2(5):407-420. doi: 10.1007/s11936-000-0036-8.

Myocarditis.

Current treatment options in cardiovascular medicine

Winkel, Costanzo, Parrillo

Affiliations

  1. Rush Heart Institute, Rush-Presbyterian-St. Luke's Medical Center, 1725 West Harrison Street, Suite 439, Chicago, IL 60612, USA. [email protected]

PMID: 11096545 DOI: 10.1007/s11936-000-0036-8

Abstract

Myocarditis and its sequela, dilated cardiomyopathy (DCM), cause substantial morbidity and mortality, especially in children and young adults. Physicians should include myocarditis in the differential diagnosis of all patients who have new symptoms of heart failure, arrhythmia, or chest pain syndromes of unclear cause, and should strongly consider performing endomyocardial biopsy (EMB) to establish the diagnosis. It may be necessary to perform multiple or serial biopsies to increase sensitivity. Patients with myocarditis and symptomatic heart failure, chest pain, or arrhythmias need hospitalization for evaluation and treatment. Patients with symptomatic left ventricular dysfunction should be treated with conventional heart failure therapy, including angiotensin-converting enzyme (ACE) inhibitors, digitalis, diuretics, and beta-blockers. Patients with arrhythmias or syncope may require electrophysiologic evaluation. In addition to conventional therapy, physicians should consider a course of immunosuppressive therapy in selected patients. The clinical course, response to therapy, and left ventricular function need close monitoring. Patients with myocarditis and rapidly progressive heart failure or cardiogenic shock should be referred early to an advanced heart failure center for implantation of a ventricular assist device and consideration for cardiac transplantation.

References

  1. N Engl J Med. 1995 Aug 3;333(5):269-75 - PubMed
  2. Curr Opin Cardiol. 1996 May;11(3):310-24 - PubMed
  3. Circulation. 1994 Jun;89(6):2582-9 - PubMed
  4. J Heart Lung Transplant. 1998 Oct;17(10):941-4 - PubMed
  5. Circulation. 1994 Jan;89(1):252-7 - PubMed
  6. Eur Heart J. 1995 Dec;16 Suppl O:147-9 - PubMed
  7. Curr Opin Cardiol. 1998 May;13(3):179-84 - PubMed
  8. N Engl J Med. 2000 Apr 13;342(15):1077-84 - PubMed
  9. J Clin Invest. 1998 Oct 1;102(7):1444-53 - PubMed
  10. Adv Virus Res. 1998;51:35-80 - PubMed
  11. Am J Cardiovasc Pathol. 1987 Jan;1(1):3-14 - PubMed
  12. Int J Sports Med. 1998 Jul;19 Suppl 3:S172-82 - PubMed
  13. J Am Coll Cardiol. 2000 Jan;35(1):11-8 - PubMed
  14. J Immunol. 1974 Dec;113(6):1726-34 - PubMed
  15. FEMS Immunol Med Microbiol. 1994 Nov;10(1):65-74 - PubMed
  16. J Virol Methods. 1997 Dec;69(1-2):7-17 - PubMed
  17. N Engl J Med. 1989 Oct 19;321(16):1061-8 - PubMed
  18. Circulation. 1997 Jan 7;95(1):133-9 - PubMed
  19. Int J Cardiol. 1996 May;54(2):157-63 - PubMed
  20. Curr Top Microbiol Immunol. 1997;223:31-52 - PubMed
  21. Circulation. 1997 Jun 3;95(11):2476-8 - PubMed
  22. Curr Treat Options Cardiovasc Med. 1999 Oct;1(3):231-242 - PubMed
  23. N Engl J Med. 2000 Mar 9;342(10):690-5 - PubMed
  24. Am Heart J. 1989 Apr;117(4):876-82 - PubMed
  25. J Am Coll Cardiol. 1995 Jul;26(1):80-4 - PubMed

Publication Types